New Recommendations to Improve Sepsis Outcomes

IDSA and a coalition of medical professional societies released recommendations for modifying the Centers for Medicare and Medicaid Services sepsis metrics to improve sepsis care and outcomes.

Expanded Use of Wastewater-Based Surveillance Unveils Emerging Flu and RSV Trends

Wastewater-based surveillance can accurately monitor influenza A and B and RSV at the population level, making it an objective tool to inform public response to common seasonal illnesses, according to research presented at IDWeek 2023.

Study Shows COVID-19 Intranasal Vaccine Candidate Produces Robust Immune Response

Two doses of a live-attenuated COVID-19 vaccine candidate produce a broad cellular immune response when administered intranasally, according to research presented at IDWeek 2023. 

IDSA Honors Infectious Diseases Leaders at IDWeek 2023

The Infectious Diseases Society of America is pleased to honor 11 infectious diseases leaders at IDWeek 2023 with Society Awards for their contributions to infectious diseases and public health.

HIVMA Recognizes Excellence in HIV Clinical Education and Research With 2023 Awards

The HIV Medicine Association is pleased to recognize three members during IDWeek 2023 for their contributions to advancing the field of HIV medicine.

HIVMA Names Allison Agwu Chair of its Board of Directors

The HIV Medicine Association is pleased to announce Allison Agwu, MD, ScM, FAAP, FIDSA, as its new chair. The Association also elected a new vice chair and named five new directors. HIVMA addresses health disparities and inequities in its mission to end the HIV epidemic. 

Steven K. Schmitt, MD, FIDSA, Named IDSA President

The Infectious Diseases Society of America is pleased to announce Steven K. Schmitt, MD, FIDSA as the Society’s new president beginning Oct. 16.

Antibiotics “Like Gold” for Some Patients: Personal Beliefs and Health Care Barriers Drive Inappropriate Antibiotic Use

Personal beliefs and health care system barriers drive antibiotic use without a prescription, according to a new qualitative study.

FDA-Approved RSV Maternal Vaccine Protects Infants, Reduces Economic Burden

A newly approved vaccine can substantially reduce the clinical and economic burden of lower respiratory tract disease caused by RSV, according to new findings presented at IDWeek 2023.

IDSA and HIVMA on Updated PrEP Recommendations

IDSA and the HIVMA welcome the U.S. Preventive Services Task Force’s updated statement reaffirming and expanding its Grade A recommendation for pre-exposure prophylaxis for the prevention of HIV among adolescents and adults.

Senate Appropriations Bill Misses Opportunity to Fund Workforce Pilot Program

The Senate’s FY 2024 Labor, Health and Human Services and State and Foreign Operations appropriations bills largely flat fund ID programs at FY 2023 levels and provide a few modest increases.

House Appropriations Bills Endanger Domestic and Global ID Programs

IDSA is disappointed that the House Labor, Health and Human Services Subcommittee did not fund the Bio-Preparedness Workforce Pilot Program in its FY 2024 appropriations bill, missing an opportunity to close the widening ID workforce gap.